Clinical value of chromosome arms 19q and 11p losses in low-grade gliomas
Agustí Alentorn(Allen Institute for Brain Science), Ahmed Idbaïh(Centre National de la Recherche Scientifique)
Cited by 15
Related Papers
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter
|Neuro-Oncology|2022|508
Detection, Characterization, and Inhibition of FGFR–TACC Fusions in IDH Wild-type Glioma
|Clinical Cancer Research|2015|285
Clinical Spectrum of Encephalitis Associated With Antibodies Against the α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor
|JAMA Neurology|2015|156